Location History:
- Silver Spring, MD (US) (1989 - 1994)
- Seneca, MD (US) (1995 - 2013)
Company Filing History:
8 out of 776 
1 out of 1 
1 out of 3 
Years Active: 1989-2013
Title: **The Innovative Contributions of Martin V Haspel**
Introduction
Martin V Haspel, an accomplished inventor based in Seneca, MD, has made significant strides in the field of biotechnology. With a remarkable portfolio of 12 patents, Haspel has dedicated his career to developing groundbreaking solutions that address critical health challenges. His work primarily focuses on antitoxin compositions and methods to combat diseases, showcasing his passion for improving human and animal health.
Latest Patents
Among Haspel's latest innovations is the patent for **Botulinum antitoxin compositions and methods**. This invention outlines a sophisticated approach to produce antitoxin compositions capable of treating both animals and humans who may have been exposed to botulism toxin. By inoculating an animal with a monovalent toxoid and toxin, collecting plasma, and purifying it via affinity chromatography, Haspel's method results in high-titered heptavalent antitoxin compositions.
Another notable invention is related to **sterile immunogenic non-tumorigenic tumor cell compositions and methods**. This patent introduces a method for producing sterile, viable, and immunogenic vaccine preparations derived from solid tumors. The process includes excising a tumor, digesting the cells, irradiating them to eliminate tumorigenicity, and ultimately sterilizing the cells, offering a promising strategy for preventing cancer recurrence.
Career Highlights
Throughout his career, Martin V Haspel has been associated with leading companies such as Akzo N.V. and Intracel Holdings LLC. His experience in these organizations has provided him with the expertise and resources to propel his inventive ideas into reality, thus influencing the fields of immunology and vaccine development.
Collaborations
Haspel has worked alongside esteemed colleagues, including Michael G Hanna, Jr. and Herbert C Hoover, Jr. Their collaborations have enriched the innovation process, allowing for a multidisciplinary approach to some of Haspel's most significant projects.
Conclusion
Martin V Haspel's contributions to the field of biotechnology through his 12 patents reflect his dedication to enhancing medical interventions and health outcomes. As he continues to innovate, Haspel's work stands as a testament to the crucial role inventors play in advancing science and medicine, ultimately contributing to a healthier future for both humans and animals.